Edition:
United States

Celsion Corp (CLSN.PH)

CLSN.PH on Philadelphia Stock Exchange

1.71USD
16 Aug 2019
Change (% chg)

-- (--)
Prev Close
$1.71
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
196
52-wk High
$2.94
52-wk Low
$1.37

About

Celsion Corporation is an oncology drug development company. The Company's product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for treatment of recurrent chest wall... (more)

Overall

Beta: 0.88
Market Cap(Mil.): $27.98
Shares Outstanding(Mil.): 8.35
Dividend: --
Yield (%): --

Financials

  CLSN.PH Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -8.37 -- --
ROI: -78.33 8.95 14.48
ROE: -191.72 10.09 15.78
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates